Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...

J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FDA) approval for treating generalised ...

Kakao Games and MMOBomb have partnered to offer you a Gift Pack key with in-game rewards for Odin: Valhalla Rising like the ...

The company said that Vyvgart (efgartigimod alfa) is the first novel mechanism of action for CIDP treatment in more than 30 years.

Overview: At the time of commissioning in March 2019, Isimba dam had over 700 defects. These included leakages in the ...

Boost immunity with diet, sleep, and stress management. Learn how to fortify your body’s defenses against infections and ...

Heart disease often manifests through warning signs that may be easy to dismiss or overlook. However, recognising these signs early and taking proactive steps can significantly reduce the risk of ...

Some dramatic cosmic quarrels are happening in conjunction with this lunar reset, but if you’re one of the signs least affected by the April 27 new moon, you may have an easier time harnessing ...

Exposing children with peanut allergy to proteins from the legume is an approved treatment to reduce the risk of allergic reactions, and now we have evidence it also works in adults ...